Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

How Vereit Inc (VER) Stacks Up Against Similarly Valued Stocks

The 700+ hedge funds and money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September 30. We went through these filings, fixed typos and other more significant errors and identified the changes in hedge fund positions. Our extensive review of these public filings is finally over, so this article is set to reveal the smart money sentiment towards Vereit Inc (NYSE:VER).

So, is Vereit Inc (NYSE:VER) a buy, sell, or hold? The smart money seems to be in a bearish mood, as the number of long hedge fund positions fell by two during the third quarter. At the end of this article we will also compare VER to other stocks, including Buckeye Partners, L.P. (NYSE:BPL), Mosaic Co (NYSE:MOS), and J.B. Hunt Transport Services, Inc. (NASDAQ:JBHT) to get a better sense of its popularity.

Follow Vereit Inc. (NYSE:VER)
Trade (NYSE:VER) Now!

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.

investment, sale, home, market, price, real, building, financing, housing, buy, property, estate, architecture, ownership, house, purchase, financial, construction, offer, sell,

designer491/Shutterstock.com

With all of this in mind, let’s take a peek at the new action surrounding Vereit Inc (NYSE:VER).

What have hedge funds been doing with Vereit Inc (NYSE:VER)?.

At the end of September, 27 investors tracked by Insider Monkey held long positions in Vereit, down by 7% over the quarter. With the smart money’s sentiment swirling, there exists a few key hedge fund managers who were upping their stakes meaningfully (or already accumulated large positions).

HedgeFundSentimentChart

When looking at the institutional investors followed by Insider Monkey, Larry Robbins’ Glenview Capital has the biggest position in Vereit Inc (NYSE:VER), worth close to $149.2 million, comprising 1.1% of its total 13F portfolio. The second largest stake is held by Jonathon Jacobson’s Highfields Capital Management, which owns a $98.6 million position; the fund has 0.9% of its 13F portfolio invested in the stock. Some other peers that hold long positions contain Jonathan Kolatch’s Redwood Capital Management, Matthew Barrett’s Glendon Capital Management, and Jeffrey Altman’s Owl Creek Asset Management.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...